• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anaphylaxis induced by mRNA COVID-19 vaccines: follow-up and booster dose after previous desensitization.

作者信息

AlOtaibi Ibtihal, Almuhizi Faisal, Ton-Leclerc Shaonie, Fein Michael, Tsoukas Christos, Garvey Lene Heise, Lee Derek, Ben-Shoshan Moshe, Isabwe Ghislaine A C, Copaescu Ana M

机构信息

Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Centre (MUHC), McGill University, Montreal, QC, Canada.

Division of Allergy and Clinical Immunology Department of Paediatrics, Central Second Health Cluster, Ministry of Health, Riyadh, Saudi Arabia.

出版信息

Front Allergy. 2023 May 3;4:1056619. doi: 10.3389/falgy.2023.1056619. eCollection 2023.

DOI:10.3389/falgy.2023.1056619
PMID:37207267
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10189778/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c0a/10189778/9956499e9479/falgy-04-1056619-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c0a/10189778/9956499e9479/falgy-04-1056619-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c0a/10189778/9956499e9479/falgy-04-1056619-g001.jpg

相似文献

1
Anaphylaxis induced by mRNA COVID-19 vaccines: follow-up and booster dose after previous desensitization.mRNA新冠疫苗诱导的过敏反应：既往脱敏后的随访及加强剂量
Front Allergy. 2023 May 3;4:1056619. doi: 10.3389/falgy.2023.1056619. eCollection 2023.
2
Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose.在一系列对第一剂新冠病毒mRNA疫苗有过敏反应病史的患者中成功实现脱敏
Front Allergy. 2022 Feb 2;3:825164. doi: 10.3389/falgy.2022.825164. eCollection 2022.
3
mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach.mRNA 疫苗预防 COVID-19 疾病和报告的过敏反应：当前证据和建议方法。
J Allergy Clin Immunol Pract. 2021 Apr;9(4):1423-1437. doi: 10.1016/j.jaip.2020.12.047. Epub 2020 Dec 31.
4
First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.mRNA COVID-19 疫苗首剂过敏反应：赋形剂皮肤试验作用有限。
J Allergy Clin Immunol Pract. 2021 Sep;9(9):3308-3320.e3. doi: 10.1016/j.jaip.2021.06.010. Epub 2021 Jun 22.
5
Anaphylaxis is a rare reaction in COVID-19 vaccination.在 COVID-19 疫苗接种中，过敏反应较为罕见。
J Biol Regul Homeost Agents. 2021 May-Jun;35(3):839-842. doi: 10.23812/BELLOMO_EDIT_3_21.
6
Intradermal Testing With COVID-19 mRNA Vaccines Predicts Tolerance.新冠病毒 mRNA 疫苗皮内试验可预测耐受性。
Front Allergy. 2022 May 31;3:818049. doi: 10.3389/falgy.2022.818049. eCollection 2022.
7
Successful mRNA COVID-19 Vaccination and Colonoscopy After Oral Desensitization in a Patient With Polyethylene Glycol Allergy.聚乙二醇过敏患者口服脱敏后成功接种 mRNA COVID-19 疫苗并完成结肠镜检查。
J Korean Med Sci. 2022 Aug 15;37(32):e251. doi: 10.3346/jkms.2022.37.e251.
8
Allergic reactions to coronavirus disease 2019 vaccines and addressing vaccine hesitancy: Northwell Health experience.对 2019 年冠状病毒病疫苗的过敏反应及应对疫苗犹豫：诺斯韦尔健康体验。
Ann Allergy Asthma Immunol. 2022 Feb;128(2):161-168.e1. doi: 10.1016/j.anai.2021.10.019. Epub 2021 Oct 24.
9
mRNA COVID-19 Vaccine Anaphylaxis: Epidemiology, Risk Factors, and Evaluation.mRNA COVID-19 疫苗过敏反应：流行病学、风险因素和评估。
Curr Allergy Asthma Rep. 2023 Mar;23(3):195-200. doi: 10.1007/s11882-023-01065-2. Epub 2023 Jan 23.
10
Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination.自报高风险过敏史与 COVID-19 疫苗接种后过敏症状的关联。
JAMA Netw Open. 2021 Oct 1;4(10):e2131034. doi: 10.1001/jamanetworkopen.2021.31034.

本文引用的文献

1
Allergic reactions to the coronavirus disease 2019 vaccine (ARCOV) study: The McGill University Health Centre experience.新型冠状病毒疾病 2019 疫苗过敏反应（ARCOV）研究：麦吉尔大学健康中心的经验。
Ann Allergy Asthma Immunol. 2022 Aug;129(2):182-188.e1. doi: 10.1016/j.anai.2022.05.014. Epub 2022 May 21.
2
What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later.我们从与严重急性呼吸综合征冠状病毒 2 型疫苗相关的变应原性和不良反应中学到了什么：一年后。
Ann Allergy Asthma Immunol. 2022 Jul;129(1):40-51. doi: 10.1016/j.anai.2022.03.030. Epub 2022 Apr 4.
3
Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose.
在一系列对第一剂新冠病毒mRNA疫苗有过敏反应病史的患者中成功实现脱敏
Front Allergy. 2022 Feb 2;3:825164. doi: 10.3389/falgy.2022.825164. eCollection 2022.
4
Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis.新型冠状病毒疫苗二次过敏反应风险：系统评价和荟萃分析。
JAMA Intern Med. 2022 Apr 1;182(4):376-385. doi: 10.1001/jamainternmed.2021.8515.
5
Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series.聚乙二醇过敏患者接种新型冠状病毒肺炎疫苗的安全性：病例系列
J Allergy Clin Immunol Pract. 2022 Feb;10(2):620-625.e1. doi: 10.1016/j.jaip.2021.11.021. Epub 2021 Dec 20.
6
Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis.聚乙二醇过敏导向的 COVID-19 疫苗过敏反应风险管理经验。
Allergy. 2022 Jul;77(7):2200-2210. doi: 10.1111/all.15183. Epub 2021 Dec 4.
7
Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose.mRNA COVID-19 疫苗第二针接种的安全性评估：首针即刻不良反应患者 **解析**：在这个翻译中，我将“Immediate Reactions”翻译为“即刻不良反应”，因为这是医学文献中常用的术语。此外，我还将“mRNA COVID-19 Vaccines”翻译为“mRNA COVID-19 疫苗”，以确保翻译的准确性和专业性。
JAMA Intern Med. 2021 Nov 1;181(11):1530-1533. doi: 10.1001/jamainternmed.2021.3779.
8
Ascertainment Bias in Anaphylaxis Safety Data of COVID-19 Vaccines.新冠疫苗过敏反应安全性数据中的确诊偏倚
J Allergy Clin Immunol Pract. 2021 Jul;9(7):2562-2566. doi: 10.1016/j.jaip.2021.04.025. Epub 2021 May 4.
9
First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.mRNA COVID-19 疫苗首剂过敏反应：赋形剂皮肤试验作用有限。
J Allergy Clin Immunol Pract. 2021 Sep;9(9):3308-3320.e3. doi: 10.1016/j.jaip.2021.06.010. Epub 2021 Jun 22.
10
Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: Don't give up on the second dose!对第一剂新型冠状病毒mRNA疫苗的过敏反应：不要放弃接种第二剂！
Allergy. 2021 Sep;76(9):2916-2920. doi: 10.1111/all.14958. Epub 2021 Jun 9.